Bacteriophages are interesting viruses that target bacteria and have been used for therapeutic purposes. Recently, the emergence of antibiotic resistance has spurred a renewed interest in using these viruses or their products as therapeutic tools against recalcitrant human pathogens. AAC has also published a recent manuscript from ARLG to guide the use of phages in clinical practice. We will discuss with experts in the field the state-of-the-art in phage therapy.
- The use of bacteriophages and their products for therapeutic purposes.
- The clinical applications of phages.
- The barriers for developing of phages as therapeutic tools to treat multidrug-resistant infections.
- Vincent A. Fischetti, Ph.D, Professor and Director, Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, NY.
- Saima Aslam, MBBS, Professor of Medicine, University of California San Diego, San Diego, Calif.
- Anthony Maresso, Ph.D., Professor and Founder of TAILOR Labs, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.
Subscribe to Editors in Conversation (free) on Apple Podcasts, Google Podcasts, Android, Spotify, via Email.